Research on Enzyme Linked Immunosorbent Assay for Erythropoietin
10.3969/j.issn.0253-9896.2009.12.012
- VernacularTitle:促红细胞生成素酶联免疫吸附测定法的研究
- Author:
Zhaowei ZENG
;
Rui WANG
;
Hui SUN
- Publication Type:Journal Article
- Keywords:
erythropoietin enzyme-linked immunosorbent assay breast neoplasms radioimmunoassay
- From:
Tianjin Medical Journal
2009;37(12):1029-1031
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To establish an enzyme linked immunosorbent assay(ELISA)for erythropoietin(EPO) in serum, and observe its clinical application value thereof. Methods: Prepare the EPO polyclonal antibody, wash the plate with isopropyl alcohol, and then choose the suitable concentration of the antibody, enzyme labeled antibody, and antigen. After the reaction, check the sensitivity, recovery, specificity and stability of the method. The serum samples of anaemia and breast carcinoma individuals were detected. The results of radioimmunodetection were compared with that of normal control group. Results: The immo-assay plate showed strong adherence to proteins. The optimal concentrations of the antibody, enzyme labelled antibody and antigen were 1∶1 000, 1∶6 000 and 1∶800 separately. The sensitivity was 0.46 U/L. The cross-reaction with growth hormone and ferritin was low. The mean recoveries of samples with high and low concentrations were 96.3%, 97.3% respectively. The coefficients of variation of intra-assay and inter-assay were just 8.31% and 7.82%, and the stability was good. The EPO levels were higher in anaemia and breast carcinoma groups than that of normal group. There was no significant difference between the results of the radioimmunodetection and ELISA. Conclusion: The double-antibody sandwich ELISA method was established for EPO in serum, which had certain clinical application value.
